Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moleculin Biotech, Inc. - Common Stock (NQ:MBRX)

0.8749 -0.0441 (-4.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 272,749
Open 0.9000
Bid (Size) 0.8600 (13)
Ask (Size) 0.8744 (1)
Prev. Close 0.9190
Today's Range 0.8450 - 0.9403
52wk Range 0.3975 - 5.470
Shares Outstanding 2,227,516
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For March 21, 2025
Via Benzinga
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025. 
Via Stocktwits

Performance

YTD
-50.6%
-50.6%
1 Month
-19.7%
-19.7%
3 Month
-49.7%
-49.7%
6 Month
-62.9%
-62.9%
1 Year
-79.6%
-79.6%

More News

Read More
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
Unusual volume stocks in Tuesday's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week
Via Stocktwits
Friday's session: top gainers and losers
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Unusual volume stocks in Friday's session
Via Chartmill
What's going on in today's session
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'
Via Benzinga
Topics Stocks
Exposures US Equities
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Keep an eye on the top gainers and losers in Thursday's session.
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Which stocks are moving on Thursday?
Via Chartmill
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?
Via Benzinga
Exposures Product Safety
Thursday's session: gap up and gap down stocks
Via Chartmill
Unusual volume stocks in Wednesday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's Going On With Moleculin Biotech Shares Wednesday?
Via Benzinga

Frequently Asked Questions

Is Moleculin Biotech, Inc. - Common Stock publicly traded?
Yes, Moleculin Biotech, Inc. - Common Stock is publicly traded.
What exchange does Moleculin Biotech, Inc. - Common Stock trade on?
Moleculin Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moleculin Biotech, Inc. - Common Stock?
The ticker symbol for Moleculin Biotech, Inc. - Common Stock is MBRX on the Nasdaq Stock Market
What is the current price of Moleculin Biotech, Inc. - Common Stock?
The current price of Moleculin Biotech, Inc. - Common Stock is 0.8749
When was Moleculin Biotech, Inc. - Common Stock last traded?
The last trade of Moleculin Biotech, Inc. - Common Stock was at 04/17/25 04:00 PM ET
What is the market capitalization of Moleculin Biotech, Inc. - Common Stock?
The market capitalization of Moleculin Biotech, Inc. - Common Stock is 1.95M
How many shares of Moleculin Biotech, Inc. - Common Stock are outstanding?
Moleculin Biotech, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.